Ewoldt, Jourdan K. https://orcid.org/0000-0001-5466-8557
DePalma, Samuel J. https://orcid.org/0000-0001-6708-5019
Jewett, Maggie E. https://orcid.org/0000-0001-7264-6634
Karakan, M. Çağatay https://orcid.org/0000-0002-7587-8913
Lin, Yih-Mei https://orcid.org/0000-0003-3959-7484
Mir Hashemian, Paria
Gao, Xining
Lou, Lihua https://orcid.org/0000-0001-5283-6211
McLellan, Micheal A. https://orcid.org/0000-0003-1946-5038
Tabares, Jonathan https://orcid.org/0000-0001-8721-2943
Ma, Marshall
Salazar Coariti, Adriana C. https://orcid.org/0000-0003-1512-5351
He, Jin https://orcid.org/0000-0002-2633-9809
Toussaint, Kimani C. Jr.
Bifano, Thomas G.
Ramaswamy, Sharan https://orcid.org/0000-0003-4108-7141
White, Alice E. https://orcid.org/0000-0002-7594-2524
Agarwal, Arvind https://orcid.org/0000-0002-7052-653X
Lejeune, Emma
Baker, Brendon M. https://orcid.org/0000-0002-2785-1070
Chen, Christopher S. https://orcid.org/0000-0003-2445-8449
Funding for this research was provided by:
National Science Foundation (EEC-1647837, EEC-1647837, GRFP, EEC-1647837, 2033654, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, GRFP, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, EEC-1647837, 2033654)
U.S. Department of Health & Human Services | National Institutes of Health (F31 HL158195-03, T32-DE007057, T32-HL125242)
Article History
Received: 11 December 2023
Accepted: 15 September 2024
First Online: 8 November 2024
Competing interests
: C.S.C. is a founder and owns shares of Satellite Biosciences, a company that is developing cell-based therapies; and Ropirio Therapeutics, a company that is developing pharmaceuticals. All other authors declare no competing interests.